nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—ulcerative colitis—colon cancer	0.679	1	CtDrD
Nicotine—SLC22A3—Irinotecan—colon cancer	0.0532	0.276	CbGbCtD
Nicotine—SLC22A3—Vincristine—colon cancer	0.0465	0.241	CbGbCtD
Nicotine—CYP2A6—Fluorouracil—colon cancer	0.0241	0.125	CbGbCtD
Nicotine—CYP2B6—Irinotecan—colon cancer	0.0163	0.0847	CbGbCtD
Nicotine—CYP2C9—Capecitabine—colon cancer	0.014	0.0725	CbGbCtD
Nicotine—CYP2C8—Fluorouracil—colon cancer	0.0119	0.0616	CbGbCtD
Nicotine—CHAT—myenteric nerve plexus—colon cancer	0.0114	0.269	CbGeAlD
Nicotine—CYP1A2—Fluorouracil—colon cancer	0.0092	0.0477	CbGbCtD
Nicotine—CYP2C9—Fluorouracil—colon cancer	0.00829	0.043	CbGbCtD
Nicotine—CYP3A4—Irinotecan—colon cancer	0.00502	0.026	CbGbCtD
Nicotine—CYP3A4—Vincristine—colon cancer	0.00439	0.0228	CbGbCtD
Nicotine—CHRNA9—embryo—colon cancer	0.00302	0.0716	CbGeAlD
Nicotine—CHRNA5—vagina—colon cancer	0.00121	0.0286	CbGeAlD
Nicotine—CYP2A13—liver—colon cancer	0.00119	0.0281	CbGeAlD
Nicotine—CHAT—lymphoid tissue—colon cancer	0.000872	0.0207	CbGeAlD
Nicotine—CHAT—digestive system—colon cancer	0.000861	0.0204	CbGeAlD
Nicotine—CHRNA10—lymphoid tissue—colon cancer	0.000839	0.0199	CbGeAlD
Nicotine—CHRNA5—lymph node—colon cancer	0.000781	0.0185	CbGeAlD
Nicotine—CHRNB2—smooth muscle tissue—colon cancer	0.000754	0.0179	CbGeAlD
Nicotine—CHRNA10—vagina—colon cancer	0.000732	0.0173	CbGeAlD
Nicotine—CHRNA3—lymphoid tissue—colon cancer	0.000585	0.0139	CbGeAlD
Nicotine—CHRNB2—bone marrow—colon cancer	0.000549	0.013	CbGeAlD
Nicotine—SLC22A2—renal system—colon cancer	0.000543	0.0129	CbGeAlD
Nicotine—CHRNB2—vagina—colon cancer	0.000526	0.0125	CbGeAlD
Nicotine—SLC22A3—embryo—colon cancer	0.000484	0.0115	CbGeAlD
Nicotine—CHRNA10—lymph node—colon cancer	0.000473	0.0112	CbGeAlD
Nicotine—CHRNA7—renal system—colon cancer	0.00046	0.0109	CbGeAlD
Nicotine—MAOB—embryo—colon cancer	0.000448	0.0106	CbGeAlD
Nicotine—SLC22A2—digestive system—colon cancer	0.000445	0.0106	CbGeAlD
Nicotine—CHRNB2—liver—colon cancer	0.000444	0.0105	CbGeAlD
Nicotine—SLC22A4—renal system—colon cancer	0.000403	0.00954	CbGeAlD
Nicotine—SLC22A1—renal system—colon cancer	0.000383	0.00909	CbGeAlD
Nicotine—MAOA—embryo—colon cancer	0.000382	0.00906	CbGeAlD
Nicotine—SLC22A3—smooth muscle tissue—colon cancer	0.000381	0.00902	CbGeAlD
Nicotine—CHRNA7—digestive system—colon cancer	0.000377	0.00894	CbGeAlD
Nicotine—CHRNA4—digestive system—colon cancer	0.000372	0.00882	CbGeAlD
Nicotine—SLC22A3—renal system—colon cancer	0.000366	0.00868	CbGeAlD
Nicotine—CHRNB2—lymph node—colon cancer	0.00034	0.00806	CbGeAlD
Nicotine—MAOB—renal system—colon cancer	0.000339	0.00804	CbGeAlD
Nicotine—CYP2A6—vagina—colon cancer	0.000333	0.00789	CbGeAlD
Nicotine—SLC22A4—digestive system—colon cancer	0.00033	0.00783	CbGeAlD
Nicotine—CHRNA3—lymph node—colon cancer	0.00033	0.00782	CbGeAlD
Nicotine—SLC22A4—bone marrow—colon cancer	0.000304	0.00722	CbGeAlD
Nicotine—SLC22A4—vagina—colon cancer	0.000292	0.00691	CbGeAlD
Nicotine—MAOA—renal system—colon cancer	0.000289	0.00686	CbGeAlD
Nicotine—CYP2A6—liver—colon cancer	0.000281	0.00665	CbGeAlD
Nicotine—MAOB—digestive system—colon cancer	0.000278	0.00659	CbGeAlD
Nicotine—SLC22A1—vagina—colon cancer	0.000278	0.00658	CbGeAlD
Nicotine—SLC22A5—renal system—colon cancer	0.000266	0.00631	CbGeAlD
Nicotine—SLC22A3—vagina—colon cancer	0.000265	0.00629	CbGeAlD
Nicotine—CYP2C8—renal system—colon cancer	0.000258	0.00611	CbGeAlD
Nicotine—CYP1A1—epithelium—colon cancer	0.000257	0.00608	CbGeAlD
Nicotine—MAOB—vagina—colon cancer	0.000246	0.00582	CbGeAlD
Nicotine—CYP2C19—digestive system—colon cancer	0.000242	0.00574	CbGeAlD
Nicotine—CYP1A2—renal system—colon cancer	0.000241	0.00572	CbGeAlD
Nicotine—CYP1A1—renal system—colon cancer	0.000238	0.00564	CbGeAlD
Nicotine—MAOA—digestive system—colon cancer	0.000237	0.00562	CbGeAlD
Nicotine—SLC22A1—liver—colon cancer	0.000234	0.00555	CbGeAlD
Nicotine—CYP2B6—renal system—colon cancer	0.000231	0.00548	CbGeAlD
Nicotine—SLC22A3—liver—colon cancer	0.000224	0.00531	CbGeAlD
Nicotine—CYP19A1—liver—colon cancer	0.00022	0.00522	CbGeAlD
Nicotine—SLC22A5—digestive system—colon cancer	0.000219	0.00518	CbGeAlD
Nicotine—CYP2E1—renal system—colon cancer	0.000217	0.00515	CbGeAlD
Nicotine—CYP2C19—vagina—colon cancer	0.000214	0.00507	CbGeAlD
Nicotine—Rhinitis—Irinotecan—colon cancer	0.00021	0.00299	CcSEcCtD
Nicotine—MAOA—vagina—colon cancer	0.00021	0.00497	CbGeAlD
Nicotine—Sinusitis—Fluorouracil—colon cancer	0.00021	0.00298	CcSEcCtD
Nicotine—Arthritis—Capecitabine—colon cancer	0.000208	0.00297	CcSEcCtD
Nicotine—Cardiac failure—Capecitabine—colon cancer	0.000208	0.00295	CcSEcCtD
Nicotine—MAOB—liver—colon cancer	0.000207	0.00491	CbGeAlD
Nicotine—Cystitis noninfective—Methotrexate—colon cancer	0.000203	0.00289	CcSEcCtD
Nicotine—Visual impairment—Irinotecan—colon cancer	0.000202	0.00287	CcSEcCtD
Nicotine—Rhinitis—Fluorouracil—colon cancer	0.000201	0.00286	CcSEcCtD
Nicotine—Cystitis—Methotrexate—colon cancer	0.000201	0.00285	CcSEcCtD
Nicotine—Cardiac disorder—Vincristine—colon cancer	0.0002	0.00284	CcSEcCtD
Nicotine—Hypoaesthesia—Fluorouracil—colon cancer	0.0002	0.00284	CcSEcCtD
Nicotine—Migraine—Capecitabine—colon cancer	0.000199	0.00284	CcSEcCtD
Nicotine—Pharyngitis—Fluorouracil—colon cancer	0.000199	0.00283	CcSEcCtD
Nicotine—CYP1A2—digestive system—colon cancer	0.000198	0.00469	CbGeAlD
Nicotine—CYP1A1—digestive system—colon cancer	0.000195	0.00463	CbGeAlD
Nicotine—Cardiac disorder—Irinotecan—colon cancer	0.000194	0.00277	CcSEcCtD
Nicotine—Flushing—Irinotecan—colon cancer	0.000194	0.00277	CcSEcCtD
Nicotine—Mediastinal disorder—Vincristine—colon cancer	0.000194	0.00276	CcSEcCtD
Nicotine—Irritability—Capecitabine—colon cancer	0.000193	0.00275	CcSEcCtD
Nicotine—SLC22A5—vagina—colon cancer	0.000193	0.00457	CbGeAlD
Nicotine—CYP2B6—lymphoid tissue—colon cancer	0.000192	0.00455	CbGeAlD
Nicotine—Mood swings—Capecitabine—colon cancer	0.000192	0.00273	CcSEcCtD
Nicotine—CYP2B6—digestive system—colon cancer	0.00019	0.0045	CbGeAlD
Nicotine—Immune system disorder—Irinotecan—colon cancer	0.000189	0.00269	CcSEcCtD
Nicotine—Mediastinal disorder—Irinotecan—colon cancer	0.000189	0.00269	CcSEcCtD
Nicotine—SLC22A4—lymph node—colon cancer	0.000189	0.00447	CbGeAlD
Nicotine—Mental disorder—Vincristine—colon cancer	0.000188	0.00268	CcSEcCtD
Nicotine—CYP2C9—digestive system—colon cancer	0.000188	0.00445	CbGeAlD
Nicotine—Bladder pain—Methotrexate—colon cancer	0.000188	0.00267	CcSEcCtD
Nicotine—Mouth ulceration—Methotrexate—colon cancer	0.000188	0.00267	CcSEcCtD
Nicotine—Arrhythmia—Irinotecan—colon cancer	0.000187	0.00266	CcSEcCtD
Nicotine—CYP2C8—vagina—colon cancer	0.000187	0.00443	CbGeAlD
Nicotine—Abdominal pain upper—Capecitabine—colon cancer	0.000185	0.00263	CcSEcCtD
Nicotine—Nasopharyngitis—Capecitabine—colon cancer	0.000181	0.00258	CcSEcCtD
Nicotine—Back pain—Vincristine—colon cancer	0.000181	0.00258	CcSEcCtD
Nicotine—CYP2C19—liver—colon cancer	0.000181	0.00428	CbGeAlD
Nicotine—CYP2E1—lymphoid tissue—colon cancer	0.00018	0.00427	CbGeAlD
Nicotine—Flatulence—Irinotecan—colon cancer	0.00018	0.00256	CcSEcCtD
Nicotine—Arrhythmia—Fluorouracil—colon cancer	0.000179	0.00255	CcSEcCtD
Nicotine—CYP2E1—digestive system—colon cancer	0.000178	0.00422	CbGeAlD
Nicotine—MAOA—liver—colon cancer	0.000177	0.00419	CbGeAlD
Nicotine—Back pain—Irinotecan—colon cancer	0.000176	0.00251	CcSEcCtD
Nicotine—Muscle spasms—Irinotecan—colon cancer	0.000175	0.00249	CcSEcCtD
Nicotine—Dysphagia—Capecitabine—colon cancer	0.000175	0.00249	CcSEcCtD
Nicotine—Influenza—Capecitabine—colon cancer	0.000175	0.00249	CcSEcCtD
Nicotine—CYP3A4—renal system—colon cancer	0.000175	0.00414	CbGeAlD
Nicotine—Erythema—Fluorouracil—colon cancer	0.000175	0.00248	CcSEcCtD
Nicotine—CYP1A1—vagina—colon cancer	0.000172	0.00409	CbGeAlD
Nicotine—Bronchospasm—Capecitabine—colon cancer	0.000172	0.00245	CcSEcCtD
Nicotine—Agitation—Vincristine—colon cancer	0.000172	0.00245	CcSEcCtD
Nicotine—CYP2D6—renal system—colon cancer	0.000172	0.00407	CbGeAlD
Nicotine—SLC22A3—lymph node—colon cancer	0.000172	0.00407	CbGeAlD
Nicotine—Sweating increased—Capecitabine—colon cancer	0.000171	0.00243	CcSEcCtD
Nicotine—Ill-defined disorder—Irinotecan—colon cancer	0.000169	0.00241	CcSEcCtD
Nicotine—CYP19A1—lymph node—colon cancer	0.000169	0.004	CbGeAlD
Nicotine—Bronchitis—Capecitabine—colon cancer	0.000168	0.0024	CcSEcCtD
Nicotine—Vertigo—Vincristine—colon cancer	0.000168	0.00239	CcSEcCtD
Nicotine—Abdominal discomfort—Capecitabine—colon cancer	0.000168	0.00239	CcSEcCtD
Nicotine—CYP2B6—vagina—colon cancer	0.000168	0.00397	CbGeAlD
Nicotine—Malaise—Irinotecan—colon cancer	0.000164	0.00234	CcSEcCtD
Nicotine—Vertigo—Irinotecan—colon cancer	0.000164	0.00233	CcSEcCtD
Nicotine—Syncope—Irinotecan—colon cancer	0.000163	0.00233	CcSEcCtD
Nicotine—SLC22A5—liver—colon cancer	0.000163	0.00386	CbGeAlD
Nicotine—Convulsion—Vincristine—colon cancer	0.000162	0.00231	CcSEcCtD
Nicotine—Hypertension—Vincristine—colon cancer	0.000162	0.0023	CcSEcCtD
Nicotine—Loss of consciousness—Irinotecan—colon cancer	0.00016	0.00228	CcSEcCtD
Nicotine—Myalgia—Vincristine—colon cancer	0.000159	0.00227	CcSEcCtD
Nicotine—Weight increased—Capecitabine—colon cancer	0.000159	0.00227	CcSEcCtD
Nicotine—Cough—Irinotecan—colon cancer	0.000159	0.00226	CcSEcCtD
Nicotine—MAOB—lymph node—colon cancer	0.000159	0.00377	CbGeAlD
Nicotine—CYP2C8—liver—colon cancer	0.000158	0.00374	CbGeAlD
Nicotine—Hypertension—Irinotecan—colon cancer	0.000157	0.00224	CcSEcCtD
Nicotine—Discomfort—Irinotecan—colon cancer	0.000153	0.00218	CcSEcCtD
Nicotine—Oedema—Vincristine—colon cancer	0.000153	0.00217	CcSEcCtD
Nicotine—Anaphylactic shock—Vincristine—colon cancer	0.000153	0.00217	CcSEcCtD
Nicotine—Stomatitis—Capecitabine—colon cancer	0.000152	0.00217	CcSEcCtD
Nicotine—Convulsion—Fluorouracil—colon cancer	0.000151	0.00215	CcSEcCtD
Nicotine—Confusional state—Irinotecan—colon cancer	0.00015	0.00213	CcSEcCtD
Nicotine—Nervous system disorder—Vincristine—colon cancer	0.00015	0.00213	CcSEcCtD
Nicotine—Anaphylactic shock—Irinotecan—colon cancer	0.000149	0.00212	CcSEcCtD
Nicotine—Oedema—Irinotecan—colon cancer	0.000149	0.00212	CcSEcCtD
Nicotine—Myalgia—Fluorouracil—colon cancer	0.000149	0.00212	CcSEcCtD
Nicotine—Chest pain—Fluorouracil—colon cancer	0.000149	0.00212	CcSEcCtD
Nicotine—Hyperhidrosis—Vincristine—colon cancer	0.000148	0.0021	CcSEcCtD
Nicotine—CYP1A2—liver—colon cancer	0.000148	0.0035	CbGeAlD
Nicotine—Epistaxis—Capecitabine—colon cancer	0.000147	0.0021	CcSEcCtD
Nicotine—Discomfort—Fluorouracil—colon cancer	0.000147	0.00209	CcSEcCtD
Nicotine—Shock—Irinotecan—colon cancer	0.000146	0.00208	CcSEcCtD
Nicotine—Nervous system disorder—Irinotecan—colon cancer	0.000146	0.00208	CcSEcCtD
Nicotine—CYP1A1—liver—colon cancer	0.000146	0.00345	CbGeAlD
Nicotine—Irritability—Methotrexate—colon cancer	0.000144	0.00205	CcSEcCtD
Nicotine—Hyperhidrosis—Irinotecan—colon cancer	0.000144	0.00205	CcSEcCtD
Nicotine—Confusional state—Fluorouracil—colon cancer	0.000144	0.00204	CcSEcCtD
Nicotine—CYP3A4—digestive system—colon cancer	0.000143	0.0034	CbGeAlD
Nicotine—Mood swings—Methotrexate—colon cancer	0.000143	0.00203	CcSEcCtD
Nicotine—Hypotension—Vincristine—colon cancer	0.000143	0.00203	CcSEcCtD
Nicotine—Anaphylactic shock—Fluorouracil—colon cancer	0.000142	0.00203	CcSEcCtD
Nicotine—Oedema—Fluorouracil—colon cancer	0.000142	0.00203	CcSEcCtD
Nicotine—CYP2B6—liver—colon cancer	0.000141	0.00335	CbGeAlD
Nicotine—CYP2D6—digestive system—colon cancer	0.000141	0.00334	CbGeAlD
Nicotine—Rhinitis—Capecitabine—colon cancer	0.00014	0.002	CcSEcCtD
Nicotine—CYP2C9—liver—colon cancer	0.00014	0.00332	CbGeAlD
Nicotine—Nervous system disorder—Fluorouracil—colon cancer	0.00014	0.00199	CcSEcCtD
Nicotine—Hypoaesthesia—Capecitabine—colon cancer	0.000139	0.00198	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000139	0.00198	CcSEcCtD
Nicotine—Pharyngitis—Capecitabine—colon cancer	0.000139	0.00198	CcSEcCtD
Nicotine—Tachycardia—Fluorouracil—colon cancer	0.000139	0.00198	CcSEcCtD
Nicotine—Hypotension—Irinotecan—colon cancer	0.000139	0.00198	CcSEcCtD
Nicotine—Insomnia—Vincristine—colon cancer	0.000138	0.00197	CcSEcCtD
Nicotine—Oedema peripheral—Capecitabine—colon cancer	0.000138	0.00196	CcSEcCtD
Nicotine—Paraesthesia—Vincristine—colon cancer	0.000137	0.00195	CcSEcCtD
Nicotine—MAOA—lymph node—colon cancer	0.000136	0.00321	CbGeAlD
Nicotine—Visual impairment—Capecitabine—colon cancer	0.000135	0.00192	CcSEcCtD
Nicotine—Insomnia—Irinotecan—colon cancer	0.000135	0.00191	CcSEcCtD
Nicotine—Paraesthesia—Irinotecan—colon cancer	0.000134	0.0019	CcSEcCtD
Nicotine—Hypotension—Fluorouracil—colon cancer	0.000133	0.00189	CcSEcCtD
Nicotine—CYP2E1—liver—colon cancer	0.000133	0.00314	CbGeAlD
Nicotine—Dyspnoea—Irinotecan—colon cancer	0.000133	0.00189	CcSEcCtD
Nicotine—Somnolence—Irinotecan—colon cancer	0.000132	0.00188	CcSEcCtD
Nicotine—Gastrointestinal disorder—Vincristine—colon cancer	0.000132	0.00188	CcSEcCtD
Nicotine—Fatigue—Vincristine—colon cancer	0.000132	0.00187	CcSEcCtD
Nicotine—Dyspepsia—Irinotecan—colon cancer	0.000131	0.00186	CcSEcCtD
Nicotine—Constipation—Vincristine—colon cancer	0.000131	0.00186	CcSEcCtD
Nicotine—Pain—Vincristine—colon cancer	0.000131	0.00186	CcSEcCtD
Nicotine—Flushing—Capecitabine—colon cancer	0.00013	0.00185	CcSEcCtD
Nicotine—Cardiac disorder—Capecitabine—colon cancer	0.00013	0.00185	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00013	0.00185	CcSEcCtD
Nicotine—Insomnia—Fluorouracil—colon cancer	0.000129	0.00183	CcSEcCtD
Nicotine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000128	0.00183	CcSEcCtD
Nicotine—Fatigue—Irinotecan—colon cancer	0.000128	0.00183	CcSEcCtD
Nicotine—Paraesthesia—Fluorouracil—colon cancer	0.000128	0.00182	CcSEcCtD
Nicotine—Constipation—Irinotecan—colon cancer	0.000127	0.00181	CcSEcCtD
Nicotine—Pain—Irinotecan—colon cancer	0.000127	0.00181	CcSEcCtD
Nicotine—Dyspnoea—Fluorouracil—colon cancer	0.000127	0.00181	CcSEcCtD
Nicotine—Somnolence—Fluorouracil—colon cancer	0.000127	0.0018	CcSEcCtD
Nicotine—Immune system disorder—Capecitabine—colon cancer	0.000127	0.0018	CcSEcCtD
Nicotine—Mediastinal disorder—Capecitabine—colon cancer	0.000126	0.0018	CcSEcCtD
Nicotine—Dyspepsia—Fluorouracil—colon cancer	0.000125	0.00178	CcSEcCtD
Nicotine—Arrhythmia—Capecitabine—colon cancer	0.000125	0.00178	CcSEcCtD
Nicotine—Abdominal discomfort—Methotrexate—colon cancer	0.000125	0.00178	CcSEcCtD
Nicotine—Gastrointestinal pain—Vincristine—colon cancer	0.000125	0.00178	CcSEcCtD
Nicotine—SLC22A5—lymph node—colon cancer	0.000125	0.00296	CbGeAlD
Nicotine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000123	0.00175	CcSEcCtD
Nicotine—Mental disorder—Capecitabine—colon cancer	0.000123	0.00175	CcSEcCtD
Nicotine—Feeling abnormal—Irinotecan—colon cancer	0.000123	0.00174	CcSEcCtD
Nicotine—Erythema—Capecitabine—colon cancer	0.000122	0.00174	CcSEcCtD
Nicotine—Pain—Fluorouracil—colon cancer	0.000122	0.00173	CcSEcCtD
Nicotine—Gastrointestinal pain—Irinotecan—colon cancer	0.000122	0.00173	CcSEcCtD
Nicotine—Abdominal pain—Vincristine—colon cancer	0.000121	0.00172	CcSEcCtD
Nicotine—Body temperature increased—Vincristine—colon cancer	0.000121	0.00172	CcSEcCtD
Nicotine—Flatulence—Capecitabine—colon cancer	0.00012	0.00171	CcSEcCtD
Nicotine—Dysgeusia—Capecitabine—colon cancer	0.000119	0.0017	CcSEcCtD
Nicotine—Back pain—Capecitabine—colon cancer	0.000118	0.00168	CcSEcCtD
Nicotine—Abdominal pain—Irinotecan—colon cancer	0.000118	0.00167	CcSEcCtD
Nicotine—Body temperature increased—Irinotecan—colon cancer	0.000118	0.00167	CcSEcCtD
Nicotine—Feeling abnormal—Fluorouracil—colon cancer	0.000117	0.00167	CcSEcCtD
Nicotine—Muscle spasms—Capecitabine—colon cancer	0.000117	0.00167	CcSEcCtD
Nicotine—Tremor—Capecitabine—colon cancer	0.000114	0.00163	CcSEcCtD
Nicotine—Stomatitis—Methotrexate—colon cancer	0.000113	0.00161	CcSEcCtD
Nicotine—Ill-defined disorder—Capecitabine—colon cancer	0.000113	0.00161	CcSEcCtD
Nicotine—Urticaria—Fluorouracil—colon cancer	0.000113	0.00161	CcSEcCtD
Nicotine—Body temperature increased—Fluorouracil—colon cancer	0.000113	0.0016	CcSEcCtD
Nicotine—Hypersensitivity—Vincristine—colon cancer	0.000113	0.0016	CcSEcCtD
Nicotine—CYP1A1—lymph node—colon cancer	0.000112	0.00264	CbGeAlD
Nicotine—Malaise—Capecitabine—colon cancer	0.00011	0.00157	CcSEcCtD
Nicotine—Epistaxis—Methotrexate—colon cancer	0.00011	0.00156	CcSEcCtD
Nicotine—Vertigo—Capecitabine—colon cancer	0.00011	0.00156	CcSEcCtD
Nicotine—Hypersensitivity—Irinotecan—colon cancer	0.00011	0.00156	CcSEcCtD
Nicotine—Asthenia—Vincristine—colon cancer	0.00011	0.00156	CcSEcCtD
Nicotine—Syncope—Capecitabine—colon cancer	0.000109	0.00156	CcSEcCtD
Nicotine—Palpitations—Capecitabine—colon cancer	0.000108	0.00153	CcSEcCtD
Nicotine—Loss of consciousness—Capecitabine—colon cancer	0.000107	0.00153	CcSEcCtD
Nicotine—CYP3A4—liver—colon cancer	0.000107	0.00253	CbGeAlD
Nicotine—Asthenia—Irinotecan—colon cancer	0.000107	0.00152	CcSEcCtD
Nicotine—Cough—Capecitabine—colon cancer	0.000106	0.00151	CcSEcCtD
Nicotine—Hypertension—Capecitabine—colon cancer	0.000105	0.0015	CcSEcCtD
Nicotine—CYP2D6—liver—colon cancer	0.000105	0.00249	CbGeAlD
Nicotine—Hypersensitivity—Fluorouracil—colon cancer	0.000105	0.00149	CcSEcCtD
Nicotine—Diarrhoea—Vincristine—colon cancer	0.000105	0.00149	CcSEcCtD
Nicotine—Arthralgia—Capecitabine—colon cancer	0.000104	0.00148	CcSEcCtD
Nicotine—Chest pain—Capecitabine—colon cancer	0.000104	0.00148	CcSEcCtD
Nicotine—Myalgia—Capecitabine—colon cancer	0.000104	0.00148	CcSEcCtD
Nicotine—Pharyngitis—Methotrexate—colon cancer	0.000104	0.00147	CcSEcCtD
Nicotine—Anxiety—Capecitabine—colon cancer	0.000103	0.00147	CcSEcCtD
Nicotine—Discomfort—Capecitabine—colon cancer	0.000103	0.00146	CcSEcCtD
Nicotine—Diarrhoea—Irinotecan—colon cancer	0.000102	0.00145	CcSEcCtD
Nicotine—Dry mouth—Capecitabine—colon cancer	0.000102	0.00145	CcSEcCtD
Nicotine—Dizziness—Vincristine—colon cancer	0.000101	0.00144	CcSEcCtD
Nicotine—Pruritus—Fluorouracil—colon cancer	0.000101	0.00143	CcSEcCtD
Nicotine—Visual impairment—Methotrexate—colon cancer	0.000101	0.00143	CcSEcCtD
Nicotine—Confusional state—Capecitabine—colon cancer	0.0001	0.00143	CcSEcCtD
Nicotine—Oedema—Capecitabine—colon cancer	9.96e-05	0.00142	CcSEcCtD
Nicotine—Dizziness—Irinotecan—colon cancer	9.84e-05	0.0014	CcSEcCtD
Nicotine—Shock—Capecitabine—colon cancer	9.79e-05	0.00139	CcSEcCtD
Nicotine—Nervous system disorder—Capecitabine—colon cancer	9.76e-05	0.00139	CcSEcCtD
Nicotine—Diarrhoea—Fluorouracil—colon cancer	9.75e-05	0.00139	CcSEcCtD
Nicotine—Tachycardia—Capecitabine—colon cancer	9.72e-05	0.00138	CcSEcCtD
Nicotine—Vomiting—Vincristine—colon cancer	9.71e-05	0.00138	CcSEcCtD
Nicotine—Cardiac disorder—Methotrexate—colon cancer	9.68e-05	0.00138	CcSEcCtD
Nicotine—Rash—Vincristine—colon cancer	9.63e-05	0.00137	CcSEcCtD
Nicotine—Hyperhidrosis—Capecitabine—colon cancer	9.62e-05	0.00137	CcSEcCtD
Nicotine—Dermatitis—Vincristine—colon cancer	9.62e-05	0.00137	CcSEcCtD
Nicotine—Headache—Vincristine—colon cancer	9.57e-05	0.00136	CcSEcCtD
Nicotine—Vomiting—Irinotecan—colon cancer	9.46e-05	0.00135	CcSEcCtD
Nicotine—Immune system disorder—Methotrexate—colon cancer	9.42e-05	0.00134	CcSEcCtD
Nicotine—Dizziness—Fluorouracil—colon cancer	9.42e-05	0.00134	CcSEcCtD
Nicotine—Mediastinal disorder—Methotrexate—colon cancer	9.4e-05	0.00134	CcSEcCtD
Nicotine—Rash—Irinotecan—colon cancer	9.38e-05	0.00133	CcSEcCtD
Nicotine—Dermatitis—Irinotecan—colon cancer	9.37e-05	0.00133	CcSEcCtD
Nicotine—Headache—Irinotecan—colon cancer	9.32e-05	0.00133	CcSEcCtD
Nicotine—Hypotension—Capecitabine—colon cancer	9.3e-05	0.00132	CcSEcCtD
Nicotine—Mental disorder—Methotrexate—colon cancer	9.14e-05	0.0013	CcSEcCtD
Nicotine—Erythema—Methotrexate—colon cancer	9.08e-05	0.00129	CcSEcCtD
Nicotine—Nausea—Vincristine—colon cancer	9.07e-05	0.00129	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Capecitabine—colon cancer	9.07e-05	0.00129	CcSEcCtD
Nicotine—Vomiting—Fluorouracil—colon cancer	9.06e-05	0.00129	CcSEcCtD
Nicotine—Insomnia—Capecitabine—colon cancer	9e-05	0.00128	CcSEcCtD
Nicotine—Rash—Fluorouracil—colon cancer	8.98e-05	0.00128	CcSEcCtD
Nicotine—Dermatitis—Fluorouracil—colon cancer	8.97e-05	0.00128	CcSEcCtD
Nicotine—Paraesthesia—Capecitabine—colon cancer	8.94e-05	0.00127	CcSEcCtD
Nicotine—Headache—Fluorouracil—colon cancer	8.92e-05	0.00127	CcSEcCtD
Nicotine—Dysgeusia—Methotrexate—colon cancer	8.89e-05	0.00127	CcSEcCtD
Nicotine—Dyspnoea—Capecitabine—colon cancer	8.88e-05	0.00126	CcSEcCtD
Nicotine—Nausea—Irinotecan—colon cancer	8.84e-05	0.00126	CcSEcCtD
Nicotine—Back pain—Methotrexate—colon cancer	8.78e-05	0.00125	CcSEcCtD
Nicotine—Dyspepsia—Capecitabine—colon cancer	8.76e-05	0.00125	CcSEcCtD
Nicotine—Gastrointestinal disorder—Capecitabine—colon cancer	8.59e-05	0.00122	CcSEcCtD
Nicotine—Fatigue—Capecitabine—colon cancer	8.58e-05	0.00122	CcSEcCtD
Nicotine—Pain—Capecitabine—colon cancer	8.51e-05	0.00121	CcSEcCtD
Nicotine—Constipation—Capecitabine—colon cancer	8.51e-05	0.00121	CcSEcCtD
Nicotine—Nausea—Fluorouracil—colon cancer	8.46e-05	0.0012	CcSEcCtD
Nicotine—Ill-defined disorder—Methotrexate—colon cancer	8.43e-05	0.0012	CcSEcCtD
Nicotine—Feeling abnormal—Capecitabine—colon cancer	8.2e-05	0.00117	CcSEcCtD
Nicotine—Malaise—Methotrexate—colon cancer	8.19e-05	0.00117	CcSEcCtD
Nicotine—Vertigo—Methotrexate—colon cancer	8.16e-05	0.00116	CcSEcCtD
Nicotine—Gastrointestinal pain—Capecitabine—colon cancer	8.14e-05	0.00116	CcSEcCtD
Nicotine—Cough—Methotrexate—colon cancer	7.92e-05	0.00113	CcSEcCtD
Nicotine—Urticaria—Capecitabine—colon cancer	7.91e-05	0.00113	CcSEcCtD
Nicotine—Body temperature increased—Capecitabine—colon cancer	7.87e-05	0.00112	CcSEcCtD
Nicotine—Abdominal pain—Capecitabine—colon cancer	7.87e-05	0.00112	CcSEcCtD
Nicotine—Convulsion—Methotrexate—colon cancer	7.87e-05	0.00112	CcSEcCtD
Nicotine—Arthralgia—Methotrexate—colon cancer	7.73e-05	0.0011	CcSEcCtD
Nicotine—Myalgia—Methotrexate—colon cancer	7.73e-05	0.0011	CcSEcCtD
Nicotine—Chest pain—Methotrexate—colon cancer	7.73e-05	0.0011	CcSEcCtD
Nicotine—Discomfort—Methotrexate—colon cancer	7.64e-05	0.00109	CcSEcCtD
Nicotine—Confusional state—Methotrexate—colon cancer	7.47e-05	0.00106	CcSEcCtD
Nicotine—Anaphylactic shock—Methotrexate—colon cancer	7.41e-05	0.00105	CcSEcCtD
Nicotine—Hypersensitivity—Capecitabine—colon cancer	7.33e-05	0.00104	CcSEcCtD
Nicotine—Nervous system disorder—Methotrexate—colon cancer	7.27e-05	0.00103	CcSEcCtD
Nicotine—Hyperhidrosis—Methotrexate—colon cancer	7.16e-05	0.00102	CcSEcCtD
Nicotine—Asthenia—Capecitabine—colon cancer	7.14e-05	0.00102	CcSEcCtD
Nicotine—Pruritus—Capecitabine—colon cancer	7.04e-05	0.001	CcSEcCtD
Nicotine—Hypotension—Methotrexate—colon cancer	6.92e-05	0.000986	CcSEcCtD
Nicotine—Diarrhoea—Capecitabine—colon cancer	6.81e-05	0.000969	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Methotrexate—colon cancer	6.75e-05	0.000961	CcSEcCtD
Nicotine—Insomnia—Methotrexate—colon cancer	6.7e-05	0.000954	CcSEcCtD
Nicotine—Paraesthesia—Methotrexate—colon cancer	6.65e-05	0.000947	CcSEcCtD
Nicotine—Dyspnoea—Methotrexate—colon cancer	6.61e-05	0.00094	CcSEcCtD
Nicotine—Somnolence—Methotrexate—colon cancer	6.59e-05	0.000938	CcSEcCtD
Nicotine—Dizziness—Capecitabine—colon cancer	6.58e-05	0.000937	CcSEcCtD
Nicotine—Dyspepsia—Methotrexate—colon cancer	6.52e-05	0.000928	CcSEcCtD
Nicotine—Gastrointestinal disorder—Methotrexate—colon cancer	6.4e-05	0.000911	CcSEcCtD
Nicotine—Fatigue—Methotrexate—colon cancer	6.39e-05	0.000909	CcSEcCtD
Nicotine—Pain—Methotrexate—colon cancer	6.34e-05	0.000902	CcSEcCtD
Nicotine—Vomiting—Capecitabine—colon cancer	6.33e-05	0.000901	CcSEcCtD
Nicotine—Rash—Capecitabine—colon cancer	6.28e-05	0.000893	CcSEcCtD
Nicotine—Dermatitis—Capecitabine—colon cancer	6.27e-05	0.000893	CcSEcCtD
Nicotine—Headache—Capecitabine—colon cancer	6.24e-05	0.000888	CcSEcCtD
Nicotine—Feeling abnormal—Methotrexate—colon cancer	6.11e-05	0.000869	CcSEcCtD
Nicotine—Gastrointestinal pain—Methotrexate—colon cancer	6.06e-05	0.000862	CcSEcCtD
Nicotine—Nausea—Capecitabine—colon cancer	5.91e-05	0.000842	CcSEcCtD
Nicotine—Urticaria—Methotrexate—colon cancer	5.89e-05	0.000838	CcSEcCtD
Nicotine—Abdominal pain—Methotrexate—colon cancer	5.86e-05	0.000834	CcSEcCtD
Nicotine—Body temperature increased—Methotrexate—colon cancer	5.86e-05	0.000834	CcSEcCtD
Nicotine—Hypersensitivity—Methotrexate—colon cancer	5.46e-05	0.000777	CcSEcCtD
Nicotine—Asthenia—Methotrexate—colon cancer	5.32e-05	0.000757	CcSEcCtD
Nicotine—Pruritus—Methotrexate—colon cancer	5.24e-05	0.000746	CcSEcCtD
Nicotine—Diarrhoea—Methotrexate—colon cancer	5.07e-05	0.000722	CcSEcCtD
Nicotine—Dizziness—Methotrexate—colon cancer	4.9e-05	0.000697	CcSEcCtD
Nicotine—Vomiting—Methotrexate—colon cancer	4.71e-05	0.000671	CcSEcCtD
Nicotine—Rash—Methotrexate—colon cancer	4.67e-05	0.000665	CcSEcCtD
Nicotine—Dermatitis—Methotrexate—colon cancer	4.67e-05	0.000664	CcSEcCtD
Nicotine—Headache—Methotrexate—colon cancer	4.64e-05	0.000661	CcSEcCtD
Nicotine—Nausea—Methotrexate—colon cancer	4.4e-05	0.000626	CcSEcCtD
Nicotine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	2.16e-05	0.00135	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CA7—colon cancer	2.12e-05	0.00132	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	2.09e-05	0.0013	CbGpPWpGaD
Nicotine—MAOA—Transmission across Chemical Synapses—BRAF—colon cancer	2.06e-05	0.00128	CbGpPWpGaD
Nicotine—CHAT—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.04e-05	0.00127	CbGpPWpGaD
Nicotine—CHAT—Metabolism—ABCB1—colon cancer	2e-05	0.00124	CbGpPWpGaD
Nicotine—CHRNB4—Transmission across Chemical Synapses—HRAS—colon cancer	1.99e-05	0.00124	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	1.99e-05	0.00124	CbGpPWpGaD
Nicotine—CYP1A1—PPARA activates gene expression—PPARG—colon cancer	1.97e-05	0.00123	CbGpPWpGaD
Nicotine—CHAT—Metabolism—TYMS—colon cancer	1.96e-05	0.00122	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CA7—colon cancer	1.94e-05	0.00121	CbGpPWpGaD
Nicotine—CHRNB2—Neuronal System—HRAS—colon cancer	1.94e-05	0.00121	CbGpPWpGaD
Nicotine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	1.93e-05	0.0012	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—CASP3—colon cancer	1.89e-05	0.00118	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—CASP3—colon cancer	1.88e-05	0.00117	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—ODC1—colon cancer	1.88e-05	0.00117	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CHST5—colon cancer	1.88e-05	0.00117	CbGpPWpGaD
Nicotine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	1.87e-05	0.00117	CbGpPWpGaD
Nicotine—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	1.86e-05	0.00116	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—CCND1—colon cancer	1.84e-05	0.00114	CbGpPWpGaD
Nicotine—CHRNA3—Transmission across Chemical Synapses—HRAS—colon cancer	1.82e-05	0.00114	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	1.82e-05	0.00113	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—CTNNB1—colon cancer	1.82e-05	0.00113	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	1.78e-05	0.00111	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—ODC1—colon cancer	1.75e-05	0.00109	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CHST5—colon cancer	1.75e-05	0.00109	CbGpPWpGaD
Nicotine—SLC22A2—Transmission across Chemical Synapses—BRAF—colon cancer	1.74e-05	0.00109	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	1.74e-05	0.00108	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CA7—colon cancer	1.73e-05	0.00108	CbGpPWpGaD
Nicotine—CHRNA7—Transmission across Chemical Synapses—HRAS—colon cancer	1.73e-05	0.00108	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CHST5—colon cancer	1.72e-05	0.00107	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—ODC1—colon cancer	1.72e-05	0.00107	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—ABCB1—colon cancer	1.7e-05	0.00106	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—EP300—colon cancer	1.69e-05	0.00105	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—ABCB1—colon cancer	1.69e-05	0.00105	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—EP300—colon cancer	1.69e-05	0.00105	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—ABCB1—colon cancer	1.68e-05	0.00105	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—TYMS—colon cancer	1.67e-05	0.00104	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	1.65e-05	0.00103	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	1.65e-05	0.00103	CbGpPWpGaD
Nicotine—CHRNA2—Transmission across Chemical Synapses—HRAS—colon cancer	1.63e-05	0.00101	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—BRAF—colon cancer	1.62e-05	0.00101	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	1.61e-05	0.001	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	1.61e-05	0.001	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	1.6e-05	0.000998	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—VEGFA—colon cancer	1.6e-05	0.000997	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CA7—colon cancer	1.6e-05	0.000995	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CA7—colon cancer	1.58e-05	0.000986	CbGpPWpGaD
Nicotine—MAOA—Neuronal System—BRAF—colon cancer	1.58e-05	0.000984	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	1.57e-05	0.000977	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	1.55e-05	0.000965	CbGpPWpGaD
Nicotine—CHRNB4—Neuronal System—HRAS—colon cancer	1.53e-05	0.000952	CbGpPWpGaD
Nicotine—CHAT—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.51e-05	0.000941	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—MYC—colon cancer	1.47e-05	0.000918	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	1.44e-05	0.000899	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—EGFR—colon cancer	1.44e-05	0.000898	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	1.44e-05	0.000896	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	1.41e-05	0.000879	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	1.41e-05	0.000879	CbGpPWpGaD
Nicotine—CHRNA4—Transmission across Chemical Synapses—HRAS—colon cancer	1.41e-05	0.000879	CbGpPWpGaD
Nicotine—CHRNA3—Neuronal System—HRAS—colon cancer	1.4e-05	0.00087	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ODC1—colon cancer	1.39e-05	0.000867	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CHST5—colon cancer	1.39e-05	0.000867	CbGpPWpGaD
Nicotine—CHAT—Metabolism—PPARG—colon cancer	1.39e-05	0.000866	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ODC1—colon cancer	1.36e-05	0.000849	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CHST5—colon cancer	1.36e-05	0.000849	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—KRAS—colon cancer	1.36e-05	0.000849	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CA7—colon cancer	1.35e-05	0.000843	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—BRAF—colon cancer	1.33e-05	0.000832	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	1.33e-05	0.00083	CbGpPWpGaD
Nicotine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	1.33e-05	0.00083	CbGpPWpGaD
Nicotine—CHRNA7—Neuronal System—HRAS—colon cancer	1.32e-05	0.000826	CbGpPWpGaD
Nicotine—CYP1A1—PPARA activates gene expression—EP300—colon cancer	1.29e-05	0.000805	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ODC1—colon cancer	1.28e-05	0.000801	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CHST5—colon cancer	1.28e-05	0.000801	CbGpPWpGaD
Nicotine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	1.26e-05	0.000788	CbGpPWpGaD
Nicotine—CHRNA2—Neuronal System—HRAS—colon cancer	1.25e-05	0.000776	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—BRAF—colon cancer	1.24e-05	0.000776	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—TP53—colon cancer	1.21e-05	0.000754	CbGpPWpGaD
Nicotine—CYP2A6—NRF2 pathway—TGFB1—colon cancer	1.2e-05	0.000749	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—PPARG—colon cancer	1.18e-05	0.000736	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ODC1—colon cancer	1.18e-05	0.000734	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CHST5—colon cancer	1.18e-05	0.000734	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	1.13e-05	0.000706	CbGpPWpGaD
Nicotine—CHAT—Metabolism—PTGS2—colon cancer	1.09e-05	0.000681	CbGpPWpGaD
Nicotine—CHRNA4—Neuronal System—HRAS—colon cancer	1.08e-05	0.000673	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.06e-05	0.00066	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CHST5—colon cancer	1.05e-05	0.000655	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ODC1—colon cancer	1.05e-05	0.000655	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CA7—colon cancer	1.04e-05	0.00065	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—AKT1—colon cancer	1.02e-05	0.000637	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—ABCB1—colon cancer	9.87e-06	0.000616	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CHST5—colon cancer	9.67e-06	0.000603	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ODC1—colon cancer	9.67e-06	0.000603	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ODC1—colon cancer	9.58e-06	0.000597	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CHST5—colon cancer	9.58e-06	0.000597	CbGpPWpGaD
Nicotine—MAOA—Transmission across Chemical Synapses—HRAS—colon cancer	9.47e-06	0.000591	CbGpPWpGaD
Nicotine—MAOB—Metabolism—ABCB1—colon cancer	9.35e-06	0.000583	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—PTGS2—colon cancer	9.29e-06	0.000579	CbGpPWpGaD
Nicotine—MAOB—Metabolism—TYMS—colon cancer	9.18e-06	0.000572	CbGpPWpGaD
Nicotine—CHAT—Metabolism—EP300—colon cancer	9.09e-06	0.000567	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.94e-06	0.000557	CbGpPWpGaD
Nicotine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	8.71e-06	0.000543	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ODC1—colon cancer	8.19e-06	0.00051	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CHST5—colon cancer	8.19e-06	0.00051	CbGpPWpGaD
Nicotine—SLC22A2—Transmission across Chemical Synapses—HRAS—colon cancer	8.01e-06	0.000499	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—ABCB1—colon cancer	7.91e-06	0.000493	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—TYMS—colon cancer	7.77e-06	0.000484	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—EP300—colon cancer	7.73e-06	0.000482	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—HRAS—colon cancer	7.47e-06	0.000465	CbGpPWpGaD
Nicotine—MAOA—Neuronal System—HRAS—colon cancer	7.26e-06	0.000452	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.03e-06	0.000438	CbGpPWpGaD
Nicotine—CHAT—Metabolism—PIK3CA—colon cancer	6.72e-06	0.000419	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PPARG—colon cancer	6.5e-06	0.000406	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CHST5—colon cancer	6.32e-06	0.000394	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ODC1—colon cancer	6.32e-06	0.000394	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—HRAS—colon cancer	6.14e-06	0.000383	CbGpPWpGaD
Nicotine—MAOA—Metabolism—ABCB1—colon cancer	5.87e-06	0.000366	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.85e-06	0.000365	CbGpPWpGaD
Nicotine—MAOA—Metabolism—TYMS—colon cancer	5.76e-06	0.000359	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—ABCB1—colon cancer	5.72e-06	0.000357	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—HRAS—colon cancer	5.72e-06	0.000357	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—PIK3CA—colon cancer	5.72e-06	0.000356	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—TYMS—colon cancer	5.62e-06	0.00035	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PPARG—colon cancer	5.5e-06	0.000343	CbGpPWpGaD
Nicotine—CHAT—Metabolism—AKT1—colon cancer	5.49e-06	0.000342	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.3e-06	0.000331	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PTGS2—colon cancer	5.12e-06	0.000319	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—ABCB1—colon cancer	4.96e-06	0.000309	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—TYMS—colon cancer	4.87e-06	0.000304	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.86e-06	0.000303	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—AKT1—colon cancer	4.67e-06	0.000291	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—ABCB1—colon cancer	4.62e-06	0.000288	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—ABCB1—colon cancer	4.55e-06	0.000284	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—TYMS—colon cancer	4.54e-06	0.000283	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—TYMS—colon cancer	4.47e-06	0.000279	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.34e-06	0.00027	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PTGS2—colon cancer	4.33e-06	0.00027	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.33e-06	0.00027	CbGpPWpGaD
Nicotine—MAOB—Metabolism—EP300—colon cancer	4.26e-06	0.000265	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.17e-06	0.00026	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PPARG—colon cancer	4.08e-06	0.000254	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PPARG—colon cancer	3.98e-06	0.000248	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.96e-06	0.000247	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.82e-06	0.000238	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ABCB1—colon cancer	3.67e-06	0.000229	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—TYMS—colon cancer	3.61e-06	0.000225	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—EP300—colon cancer	3.6e-06	0.000224	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ABCB1—colon cancer	3.6e-06	0.000224	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—TYMS—colon cancer	3.53e-06	0.00022	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.47e-06	0.000216	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PPARG—colon cancer	3.45e-06	0.000215	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.41e-06	0.000213	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ABCB1—colon cancer	3.39e-06	0.000212	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.38e-06	0.000211	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—TYMS—colon cancer	3.33e-06	0.000208	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PPARG—colon cancer	3.22e-06	0.000201	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PTGS2—colon cancer	3.21e-06	0.0002	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.18e-06	0.000198	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PPARG—colon cancer	3.17e-06	0.000198	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PIK3CA—colon cancer	3.15e-06	0.000196	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PTGS2—colon cancer	3.13e-06	0.000195	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.11e-06	0.000194	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ABCB1—colon cancer	3.11e-06	0.000194	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—TYMS—colon cancer	3.06e-06	0.00019	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.84e-06	0.000177	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ABCB1—colon cancer	2.78e-06	0.000173	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—TYMS—colon cancer	2.73e-06	0.00017	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PTGS2—colon cancer	2.72e-06	0.000169	CbGpPWpGaD
Nicotine—MAOA—Metabolism—EP300—colon cancer	2.67e-06	0.000166	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PIK3CA—colon cancer	2.66e-06	0.000166	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.66e-06	0.000166	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—EP300—colon cancer	2.6e-06	0.000162	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.59e-06	0.000161	CbGpPWpGaD
Nicotine—MAOB—Metabolism—AKT1—colon cancer	2.57e-06	0.00016	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.57e-06	0.00016	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PPARG—colon cancer	2.56e-06	0.000159	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ABCB1—colon cancer	2.55e-06	0.000159	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ABCB1—colon cancer	2.53e-06	0.000158	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PTGS2—colon cancer	2.53e-06	0.000158	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—TYMS—colon cancer	2.51e-06	0.000156	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PPARG—colon cancer	2.5e-06	0.000156	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PTGS2—colon cancer	2.49e-06	0.000155	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—TYMS—colon cancer	2.49e-06	0.000155	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PPARG—colon cancer	2.36e-06	0.000147	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.35e-06	0.000147	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—EP300—colon cancer	2.26e-06	0.000141	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.21e-06	0.000138	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—AKT1—colon cancer	2.18e-06	0.000136	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PPARG—colon cancer	2.16e-06	0.000135	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ABCB1—colon cancer	2.16e-06	0.000135	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—TYMS—colon cancer	2.13e-06	0.000132	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—EP300—colon cancer	2.1e-06	0.000131	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.1e-06	0.000131	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—EP300—colon cancer	2.07e-06	0.000129	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PTGS2—colon cancer	2.01e-06	0.000125	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PIK3CA—colon cancer	1.98e-06	0.000123	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PTGS2—colon cancer	1.97e-06	0.000123	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PPARG—colon cancer	1.93e-06	0.00012	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PIK3CA—colon cancer	1.93e-06	0.00012	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.91e-06	0.000119	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTGS2—colon cancer	1.86e-06	0.000116	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PPARG—colon cancer	1.78e-06	0.000111	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PPARG—colon cancer	1.76e-06	0.00011	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTGS2—colon cancer	1.7e-06	0.000106	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—EP300—colon cancer	1.67e-06	0.000104	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PIK3CA—colon cancer	1.67e-06	0.000104	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ABCB1—colon cancer	1.67e-06	0.000104	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—TYMS—colon cancer	1.64e-06	0.000102	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—EP300—colon cancer	1.64e-06	0.000102	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.64e-06	0.000102	CbGpPWpGaD
Nicotine—MAOA—Metabolism—AKT1—colon cancer	1.61e-06	0.000101	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—AKT1—colon cancer	1.57e-06	9.81e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PIK3CA—colon cancer	1.56e-06	9.71e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—EP300—colon cancer	1.54e-06	9.63e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PIK3CA—colon cancer	1.53e-06	9.56e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTGS2—colon cancer	1.52e-06	9.48e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PPARG—colon cancer	1.51e-06	9.39e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—EP300—colon cancer	1.42e-06	8.83e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTGS2—colon cancer	1.4e-06	8.72e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTGS2—colon cancer	1.39e-06	8.64e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—AKT1—colon cancer	1.36e-06	8.51e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—AKT1—colon cancer	1.27e-06	7.93e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—EP300—colon cancer	1.26e-06	7.88e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—AKT1—colon cancer	1.25e-06	7.81e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3CA—colon cancer	1.24e-06	7.71e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3CA—colon cancer	1.21e-06	7.56e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTGS2—colon cancer	1.18e-06	7.38e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—EP300—colon cancer	1.16e-06	7.25e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PPARG—colon cancer	1.16e-06	7.24e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—EP300—colon cancer	1.15e-06	7.19e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3CA—colon cancer	1.14e-06	7.12e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3CA—colon cancer	1.05e-06	6.53e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—AKT1—colon cancer	1.01e-06	6.3e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—AKT1—colon cancer	9.9e-07	6.17e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—EP300—colon cancer	9.85e-07	6.14e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3CA—colon cancer	9.35e-07	5.83e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—AKT1—colon cancer	9.33e-07	5.82e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTGS2—colon cancer	9.14e-07	5.7e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3CA—colon cancer	8.6e-07	5.36e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—AKT1—colon cancer	8.56e-07	5.34e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3CA—colon cancer	8.53e-07	5.32e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—AKT1—colon cancer	7.64e-07	4.76e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—EP300—colon cancer	7.6e-07	4.74e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3CA—colon cancer	7.29e-07	4.54e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—AKT1—colon cancer	7.03e-07	4.38e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—AKT1—colon cancer	6.96e-07	4.34e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—AKT1—colon cancer	5.95e-07	3.71e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3CA—colon cancer	5.62e-07	3.51e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—AKT1—colon cancer	4.59e-07	2.86e-05	CbGpPWpGaD
